hit counter
Arcturus Therapeutics Ltd. (ARCT) Stock News Sentiment & Price - Sentifly
ARCT - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Arcturus Therapeutics Ltd. (ARCT)

USA
Biotechnology
NASDAQ
ARCT Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ARCT Latest news
Business Wire
Neutral
Arcturus Therapeutics Announces Leadership Appointments
2021-10-21 08:00

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Announces Leadership Appointments

Business Wire
Neutral
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2021-10-20 20:00

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The Motley Fool
Neutral
Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?
2021-10-15 06:00

The company disappointed last year, but things may be turning around.

Business Wire
Neutral
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 3b Study for ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
2021-10-12 08:00

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the Vietnam Ministry of Health has approved initiation of the Phase 3b part of the placebo-controlled, observer-blind Phase 1/2/3 clinical trial of ARCT-154 self-replicating RNA vacc

The Motley Fool
Neutral
After COVID-19, Could This Be the Next Billion-Dollar Vaccine Market?
2021-10-04 06:00

Three healthcare giants are vying for the prize.

Business Wire
Neutral
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
2021-09-22 16:01

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration

Business Wire
Neutral
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other Variants of Concern
2021-09-22 07:00

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine

Seeking Alpha
Positive
Arcturus Therapeutics Presents Specific Asian COVID-19 Opportunity
2021-09-10 06:36

The company has a specific opportunity to be a vaccine supplier within Asia and to the world.

InvestorPlace
Positive
7 Busted Biotech Stocks Due for a Rebound
2021-09-08 12:25

Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally. The post 7 Busted Biotech Stocks Due for a Rebound appeared first on InvestorPlace.

Business Wire
Neutral
Arcturus Therapeutics to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021
2021-09-08 09:00

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021

Loading more news...